Acrivon Therapeutics ACRV Cash Flow Statement (2021-2026)

NASDAQ ACRV
$1.85 +0.06 (+3.06%)
As of: Oct 21, 2026 · 10:07 AM EDT
Reported Financials

Acrivon Therapeutics Quarterly Cash Flow Statement

Periods 20 quarters
Latest Jun 2026

Acrivon Therapeutics reported cash from operations of -$14.86M and free cash flow of -$14.95M for the quarter ended Jun 2026, up 10.5% year over year. This cash flow statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -2.44M-4.34M-7.22M-5.82M-9.20M-8.93M-12.76M-13.91M-14.47M-19.25M-16.49M-18.80M-22.44M-22.83M-19.68M-21.01M-18.23M-18.99M-19.04M-17.96M
Depreciation and DepletionDep. & Depletion 0.01M0.01M0.05M0.10M0.10M0.16M0.13M0.10M0.10M0.14M0.22M0.20M0.30M0.30M0.31M0.30M0.30M0.40M0.40M0.40M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.01M0.01M0.05M0.10M0.10M0.16M0.13M0.10M0.10M0.14M0.22M0.20M0.30M0.30M0.31M0.30M0.30M0.40M0.40M0.40M
Share-based CompensationStock Comp. 0.03M0.30M0.04M0.23M0.27M1.65M2.65M2.69M3.23M3.06M3.34M3.57M3.67M3.71M3.79M3.93M3.91M3.09M2.18M2.21M
Other non-cash itemsOther Non-Cash 0.20M0.18M0.18M0.18M0.19M0.19M0.20M0.20M0.19M0.22M0.23M0.24M0.24M0.25M0.26M0.26M0.27M0.27M0.28M
Change in Working Capital
Change in Account PayablesChange Payables 0.30M-0.10M0.54M0.03M-0.73M0.47M-0.11M0.08M3.17M-2.27M-0.94M-0.14M-0.23M2.82M-2.55M-0.01M1.28M-1.20M-0.21M
Change in Accured ExpensesChange Accured Exp. 1.00M-0.33M0.74M0.98M1.53M-1.32M1.43M2.02M1.04M-1.48M2.87M3.46M3.18M-7.00M2.15M1.97M-0.48M-3.38M0.71M
Change in Other Operating AssetsOther Assets Change 0.63M0.88M1.61M-1.45M2.50M-0.59M-1.42M0.07M-0.17M-0.14M-0.27M0.89M0.47M-0.47M-0.70M0.22M0.62M-0.38M0.05M
Change in Other Operating LiabilitiesOther Liabilities Change -0.26M-0.16M-0.16M-0.17M-0.18M-0.18M-0.19M-0.18M-0.21M-0.20M-0.22M-0.26M-0.37M-0.13M-0.25M-0.27M-0.28M-0.29M-0.30M
Other Working Capital ChangesOther WC Changes -0.89M-1.04M-1.78M1.28M-2.67M0.42M1.24M-0.26M-0.05M-0.06M0.05M-1.15M-0.83M0.34M0.45M-0.50M-0.90M0.09M-0.35M
Cash from OperationsCash from Ops. -3.63M-8.42M-5.82M-6.52M-9.35M-11.36M-9.11M-9.81M-12.37M-17.08M-13.90M-17.32M-17.36M-19.54M-16.61M-12.28M-15.24M-20.54M-14.86M
Investing Activities
Capital ExpendituresCapex 0.14M0.42M1.07M0.43M0.25M0.03M0.11M1.15M0.82M0.14M0.99M0.83M0.06M0.49M0.90M0.22M0.01M0.09M
Change in Property, Plant and EquipmentChange in PP&E -0.14M-0.42M-1.07M-0.43M-0.25M-0.03M-0.11M-1.15M-0.82M-0.14M-0.99M-0.83M-0.06M-0.49M-0.90M-0.22M-0.01M-0.09M
Purchase of InvestmentsInvestments Purchased 100.81M16.96M22.98M16.58M28.34M134.83M5.00M34.76M20.23M15.06M33.19M13.26M16.86M9.97M
Sale and Maturity of InvestmentsInvestments Sold 6.00M26.32M19.45M24.50M38.27M35.00M46.93M22.00M50.00M39.50M35.00M40.00M35.00M30.00M25.00M
Cash from Investing ActivitiesCash from Investing -0.14M-0.42M-1.07M-45.12M-95.07M9.33M19.34M1.52M20.54M5.85M-88.04M16.01M14.41M19.21M19.45M5.91M21.52M13.13M14.95M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 104.46M0.08M0.32M0.08M130.01M0.00M7.31M
Net Shares Issued and RepurchasedNet Shares Issued 104.46M0.08M0.32M0.08M130.01M0.00M7.31M
Net Equity Issued and RepurchasedNet Equity Issued 104.46M0.08M0.32M0.08M130.01M0.00M7.31M
Other financing activitiesOther financing 0.19M-2.95M-0.25M-6.66M-1.50M-0.65M-0.34M-0.10M-0.12M-0.19M-0.03M-0.04M
Cash from Financing ActivitiesCash from Financing 99.75M-0.14M101.86M0.08M-2.01M-0.17M123.35M-1.50M-0.65M-0.34M-0.10M-0.12M-0.19M-0.03M7.27M
Additional items
Change in Cash 95.99M-8.83M-6.91M-51.78M-2.56M-2.03M10.61M-8.21M6.16M-11.41M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.10M-7.44M7.35M
Ending Cash Balance 4.00M99.99M91.16M84.25M32.47M29.91M27.88M38.48M30.27M36.43M25.02M46.43M43.61M40.02M39.35M42.10M35.61M41.70M34.26M41.61M
Free Cash FlowFCF -3.76M-8.83M-6.90M-6.95M-9.61M-11.38M-9.22M-9.81M-13.52M-17.90M-14.04M-18.31M-18.19M-19.59M-17.10M-13.18M-15.46M-20.55M-14.95M
Net Cash FlowNCF 95.99M-8.83M-6.90M-51.78M-2.56M-2.03M10.23M-8.21M6.16M-11.41M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.10M-7.44M7.35M

Acrivon Therapeutics Cash Flow Statement API

Pull Acrivon Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACRV&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY